We have advised Armira on raising finance to support its partnership with Osypka AG (Osypka), a leading German MedTech company which provides mission-critical cardio products and CDMO services for neuromodulation solutions.
Osypka is an internationally recognised provider and partner for innovative medical technology, offering advanced products for interventional and paediatric cardiology as well as cardiac surgery, providing global contract partners with technically and qualitatively sophisticated turnkey CDMO solutions, particularly in electrically active implants and neurostimulation. Since its founding in 1977 by Prof. Dr. Peter Osypka, the company has stood for technical excellence, improving the quality of life and care for patients worldwide.
Armira is a Munich-based investment holding company focused on direct equity investments in medium-sized, profitable family businesses as well as resilient growth companies in the DACH region, Italy and beyond. Backed by an exclusive investor base of entrepreneurs and families, Armira offers capital and strategic support with a long-term perspective.
